177 related articles for article (PubMed ID: 32614274)
21. Long-term oncologic outcomes after radiofrequency ablation for T1 renal cell carcinoma.
Psutka SP; Feldman AS; McDougal WS; McGovern FJ; Mueller P; Gervais DA
Eur Urol; 2013 Mar; 63(3):486-92. PubMed ID: 22959191
[TBL] [Abstract][Full Text] [Related]
22. Oncologic outcomes in patients treated with endoscopic robot assisted simple enucleation (ERASE) for renal cell carcinoma: Results from a tertiary referral center.
Mari A; Di Maida F; Tellini R; Campi R; Sforza S; Cocci A; Siena G; Vittori G; Tuccio A; Masieri L; Lapini A; Raspollini MR; Carini M; Minervini A
Eur J Surg Oncol; 2019 Oct; 45(10):1977-1982. PubMed ID: 30981447
[TBL] [Abstract][Full Text] [Related]
23. Predictors of oncological outcome after resection of locally recurrent renal cell carcinoma.
Margulis V; McDonald M; Tamboli P; Swanson DA; Wood CG
J Urol; 2009 May; 181(5):2044-51. PubMed ID: 19286220
[TBL] [Abstract][Full Text] [Related]
24. 10-year oncologic outcomes after laparoscopic and open partial nephrectomy.
Lane BR; Campbell SC; Gill IS
J Urol; 2013 Jul; 190(1):44-9. PubMed ID: 23306087
[TBL] [Abstract][Full Text] [Related]
25. Tumor volume: a new prognostic factor of oncological outcome of localized clear cell renal cell carcinoma.
Chen SH; Xu LY; Wu YP; Ke ZB; Huang P; Lin F; Li XD; Xue XY; Wei Y; Zheng QS; Xu N
BMC Cancer; 2021 Jan; 21(1):79. PubMed ID: 33468079
[TBL] [Abstract][Full Text] [Related]
26. Female Gender Predicts Favorable Prognosis in Patients With Non-metastatic Clear Cell Renal Cell Carcinoma Undergoing Curative Surgery: Results From the International Marker Consortium for Renal Cancer (INMARC).
Fukushima H; Saito K; Yasuda Y; Tanaka H; Patil D; Cotta BH; Patel SH; Master VA; Derweesh IH; Fujii Y
Clin Genitourin Cancer; 2020 Apr; 18(2):111-116.e1. PubMed ID: 32001181
[TBL] [Abstract][Full Text] [Related]
27. A prospective, randomised EORTC intergroup phase 3 study comparing the oncologic outcome of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma.
Van Poppel H; Da Pozzo L; Albrecht W; Matveev V; Bono A; Borkowski A; Colombel M; Klotz L; Skinner E; Keane T; Marreaud S; Collette S; Sylvester R
Eur Urol; 2011 Apr; 59(4):543-52. PubMed ID: 21186077
[TBL] [Abstract][Full Text] [Related]
28. Comparison of Partial and Radical Laparascopic Nephrectomy: Long-Term Outcomes for Clinical T1b Renal Cell Carcinoma.
Cai Y; Li HZ; Zhang YS
Urol J; 2018 Mar; 15(2):16-20. PubMed ID: 29464682
[TBL] [Abstract][Full Text] [Related]
29. Positive Surgical Margins Increase Risk of Recurrence after Partial Nephrectomy for High Risk Renal Tumors. Shah PH, Moreira DM, Okhunov Z, Patel VR, Chopra S, Razmaria AA, Alom M, George AK, Yaskiv O, Schwartz MJ, Desai M, Vira MA, Richstone L, Landman J, Shalhav AL, Gill I, Kavoussi LR. J Urol. 2016 Aug;196(2):327-34.
Kryvenko ON
Urol Oncol; 2017 Jun; 35(6):449-450. PubMed ID: 28416109
[TBL] [Abstract][Full Text] [Related]
30. Surgical Approach Does Not Impact Margin Status After Partial Nephrectomy for Large Renal Masses.
Ayangbesan A; Golombos DM; Golan R; O'Malley P; Lewicki P; Wu X; Scherr DS
J Endourol; 2019 Jan; 33(1):50-60. PubMed ID: 29914269
[TBL] [Abstract][Full Text] [Related]
31. Disease outcome in patients with low stage renal cell carcinoma treated with nephron sparing or radical surgery.
Lerner SE; Hawkins CA; Blute ML; Grabner A; Wollan PC; Eickholt JT; Zincke H
J Urol; 1996 Jun; 155(6):1868-73. PubMed ID: 8618276
[TBL] [Abstract][Full Text] [Related]
32. Long-term oncologic outcomes of minimally invasive partial nephrectomy for renal-cell carcinoma.
Mukkamala A; He C; Weizer AZ; Hafez KS; Miller DC; Montgomery JS; Wolf JS
J Endourol; 2014 Jun; 28(6):649-54. PubMed ID: 24405274
[TBL] [Abstract][Full Text] [Related]
33. Pathological T3a Upstaging of Clinical T1 Renal Cell Carcinoma: Outcomes According to Surgical Technique and Predictors of Upstaging.
Jeong SH; Kim JK; Park J; Jeon HJ; Yoon MY; Jeong CW; Ku JH; Kim HH; Kwak C
PLoS One; 2016; 11(11):e0166183. PubMed ID: 27861519
[TBL] [Abstract][Full Text] [Related]
34. Renal cell carcinoma with vena caval involvement: a contemporary clinicopathologic analysis of 53 cases.
Nwadei IU; Lorentz A; Patil D; Dimarco MA; Master VA; Osunkoya AO
Hum Pathol; 2016 Mar; 49():83-9. PubMed ID: 26826414
[TBL] [Abstract][Full Text] [Related]
35. A Multigene Signature Based on Cell Cycle Proliferation Improves Prediction of Mortality Within 5 Yr of Radical Nephrectomy for Renal Cell Carcinoma.
Morgan TM; Mehra R; Tiemeny P; Wolf JS; Wu S; Sangale Z; Brawer M; Stone S; Wu CL; Feldman AS
Eur Urol; 2018 May; 73(5):763-769. PubMed ID: 29249291
[TBL] [Abstract][Full Text] [Related]
36. Long-term oncologic outcomes of hand-assisted laparoscopic radical nephrectomy for clinically localized renal cell carcinoma: a multi-institutional comparative study.
Park YH; Lee ES; Kim HH; Kwak C; Ku JH; Lee SE; Byun SS; Hong SK; Kim YJ; Kang SH; Hong SH
J Laparoendosc Adv Surg Tech A; 2014 Aug; 24(8):556-62. PubMed ID: 25007232
[TBL] [Abstract][Full Text] [Related]
37. The influence of pNx/pN0 grouping in a multivariate setting for outcome modeling in patients with clear cell renal cell carcinoma.
Ward JF; Blute ML; Cheville JC; Lohse CM; Weaver AL; Zincke H
J Urol; 2002 Jul; 168(1):56-60. PubMed ID: 12050492
[TBL] [Abstract][Full Text] [Related]
38. Laparoscopic radical versus partial nephrectomy for tumors >4 cm: intermediate-term oncologic and functional outcomes.
Simmons MN; Weight CJ; Gill IS
Urology; 2009 May; 73(5):1077-82. PubMed ID: 19394509
[TBL] [Abstract][Full Text] [Related]
39. Renal Cell Carcinoma with Isolated Lymph Node Involvement: Long-term Natural History and Predictors of Oncologic Outcomes Following Surgical Resection.
Gershman B; Moreira DM; Thompson RH; Boorjian SA; Lohse CM; Costello BA; Cheville JC; Leibovich BC
Eur Urol; 2017 Aug; 72(2):300-306. PubMed ID: 28094055
[TBL] [Abstract][Full Text] [Related]
40. Impact of positive surgical margins on overall survival after partial nephrectomy-A matched comparison based on the National Cancer Database.
Shum CF; Bahler CD; Sundaram CP
Urol Oncol; 2018 Mar; 36(3):90.e15-90.e21. PubMed ID: 29223360
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
